HHTM

STAFA, SWITZERLAND – Phonak has successfully launched the Hear My Life Ambassador Relay, beginning with an engaging two-day event featuring World Cup skier Robin Gillon and Olympic sprint kayaker Aaron Small on February 20-21, 2025. Designed to connect Phonak’s brand ambassadors across sports, music, and beyond, the relay highlights individuals who break barriers and inspire people with hearing loss. Both

TARRYTOWN, NEW YORK – Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced updated data from the Phase 1/2 CHORD trial evaluating the investigational gene therapy DB-OTO in children with profound genetic hearing loss caused by otoferlin (OTOF) gene variants. The latest findings, presented at the Association for Research in Otolaryngology’s (ARO) 48th Annual MidWinter Meeting, include 72-week results showing speech and

by Tim Plunkett Recently I had the unexpected  opportunity to compare wearing two pair of hearing aids (same brand, model, and technology level), with my exact same prescription programing. The only difference – one pair was fitted using Real Ear Measurement (REM), and the other was not. Was there a difference? Yes, and it was huge! I was diagnosed with

LOS ANGELES, CALIFORNIA — The brain may play a role in helping the ear regulate its sensitivity to sound and compensate for hearing loss by sending a signal to the cochlea, according to a study that was just published in the Journal of Neuroscience. The discovery could help researchers develop treatments for tough-to-treat hearing disorders such as hyperacusis, where everyday

Access to communication is a fundamental right, yet for many individuals who are Deaf or hard of hearing in the prison system, it remains a significant challenge. In this discussion, Paul Lee, COO of InnoCaption, joins Shari Eberts to discuss InnoCaption Connect, a program designed to bring real-time captioned calls to incarcerated individuals. With an estimated 10% of the prison

LYNGE, DENMARK – Signia, a provider of advanced hearing solutions and a part of WSA, has introduced the Pure Charge&Go BCT IX, a hearing aid that combines Bluetooth® Classic compatibility with extended battery performance. Offering up to 36 hours of battery life, including five hours of streaming, this device provides connectivity without compromising on design or functionality. The Pure Charge&Go

Registration is now open for exhibitors at the 69th International Congress of Hearing Aid Acousticians (EUHA), taking place from 22–24 October 2025 in Nuremberg. As of 12 February 2025, companies can secure exhibition space at the event via www.ausstellung-euha.org/en. On the first day of registration alone, more than 20 companies confirmed their participation. New Exhibition Hall & Expanded EUHA Live

Conductive hearing loss (CHL) in children presents unique challenges and is often managed through surgical interventions or external hearing devices. Conventional approaches, including bone-anchored hearing aids and corrective surgeries, can be effective but may involve multiple surgical procedures, continuous device upkeep, and potential challenges such as skin irritation and discomfort. A new study published in Communications Engineering explores an innovative,

MONTPELLIER, FRANCE — Sensorion (FR0012596468 – ALSEN), a clinical-stage biotechnology company specializing in novel therapies for hearing loss, announced that the Data Monitoring Committee (DMC) has recommended the continuation of the Audiogene Phase 1/2 clinical trial of SENS-501, a gene therapy program aimed at treating congenital deafness caused by OTOF (otoferlin) gene mutations. The DMC’s recommendation follows a review of

SEATTLE, WASHINGTON – Sound Pharmaceuticals will present new preclinical and clinical data on SPI-1005 at the upcoming Association for Research in Otolaryngology (ARO) MidWinter Meeting in Orlando, FL. The company will deliver four presentations highlighting advancements in hearing loss and tinnitus research, including findings on ebselen’s potential to reverse noise-induced tinnitus and SPI-1005’s efficacy in Meniere’s disease treatment. Presentations at